Displaying 13 - 24 of 27
Immune-Mediated and Cholestatic Diseases
Welcome & objectives

Welcome & objectives

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Key considerations in the management of cirrhosis in PBC

Key considerations in the management of cirrhosis in PBC

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A

Q&A

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Does our increasing knowledge of PBC pathogenesis affect early management?

Does our increasing knowledge of PBC pathogenesis affect early management?

Webcasts
View
Immune-Mediated and Cholestatic Diseases
Enhancing clinical care strategies in PBC

Enhancing clinical care strategies in PBC

Webcasts
View
Metabolism, Alcohol & Toxicity

The NASH care pathway: Drivers and emerging trends

Webcasts
View
Metabolism, Alcohol & Toxicity

How to optimise NASH patient care? – Collaboration with different specialities

Webcasts
View
Metabolism, Alcohol & Toxicity

How do non-invasive techniques improve patient identification and risk stratification?

Webcasts
View
Metabolism, Alcohol & Toxicity

Future improvements needed for care pathways for patients with NASH – Q&A

Webcasts
View
General Hepatology

Chair’s welcome

Webcasts
View
General Hepatology

New insights into the role of FXR agonism in PBC

Webcasts
View
General Hepatology

Obethicolic Acid in the real world: what have we learned so far? Experience from Spain and Portugal

Webcasts
View
Displaying 13 - 24 of 27